Details, Fiction and Healthcare News
Novo CEO pressed by Senate to cut price ranges of obesity, diabetes medicine CEO Lars Fruergaard Jørgensen informed lawmakers the organization would look at new talks with insurers in regards to the list costs of Wegovy and copyright if they pledge to keep the medicines on their formularies.Previously this summer, the organization held lengthy neg